Annual CFI
$54.03 M
-$399.11 M-88.08%
31 December 2023
Summary:
BridgeBio Pharma annual cash flow from investing activities is currently $54.03 million, with the most recent change of -$399.11 million (-88.08%) on 31 December 2023. During the last 3 years, it has risen by +$107.03 million (+201.96%). BBIO annual CFI is now -88.08% below its all-time high of $453.15 million, reached on 31 December 2022.BBIO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$38.23 M
+$35.19 M+1157.85%
30 September 2024
Summary:
BridgeBio Pharma quarterly cash flow from investing activities is currently $38.23 million, with the most recent change of +$35.19 million (+1157.85%) on 30 September 2024. Over the past year, it has increased by +$544.00 thousand (+1.44%). BBIO quarterly CFI is now -74.47% below its all-time high of $149.70 million, reached on 30 June 2022.BBIO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$63.95 M
+$544.00 K+0.86%
30 September 2024
Summary:
BridgeBio Pharma TTM cash flow from investing activities is currently $63.95 million, with the most recent change of +$544.00 thousand (+0.86%) on 30 September 2024. Over the past year, it has dropped by -$8.11 million (-11.26%). BBIO TTM CFI is now -86.01% below its all-time high of $456.98 million, reached on 30 September 2022.BBIO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BBIO Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -88.1% | +1.4% | -11.3% |
| 3 y3 years | +202.0% | -35.2% | +145.8% |
| 5 y5 years | +356.9% | +119.4% | +131.4% |
BBIO Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -88.1% | +126.9% | -74.5% | >+9999.0% | -86.0% | +131.8% |
| 5 y | 5 years | -88.1% | +124.9% | -74.5% | +113.5% | -86.0% | +117.1% |
| alltime | all time | -88.1% | +124.9% | -74.5% | +113.5% | -86.0% | +117.1% |
BridgeBio Pharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $38.23 M(+1157.8%) | $63.95 M(+0.9%) |
| June 2024 | - | $3.04 M(-86.6%) | $63.41 M(-1.7%) |
| Mar 2024 | - | $22.75 M(<-9900.0%) | $64.49 M(+19.3%) |
| Dec 2023 | $54.03 M(-88.1%) | -$66.00 K(-100.2%) | $54.03 M(-25.0%) |
| Sept 2023 | - | $37.68 M(+814.8%) | $72.06 M(-60.2%) |
| June 2023 | - | $4.12 M(-66.5%) | $181.24 M(-44.5%) |
| Mar 2023 | - | $12.30 M(-31.5%) | $326.82 M(-27.9%) |
| Dec 2022 | $453.15 M(-325.6%) | $17.96 M(-87.8%) | $453.15 M(-0.8%) |
| Sept 2022 | - | $146.86 M(-1.9%) | $456.98 M(+23.8%) |
| June 2022 | - | $149.70 M(+8.0%) | $369.09 M(+67.9%) |
| Mar 2022 | - | $138.62 M(+535.9%) | $219.85 M(-209.5%) |
| Dec 2021 | -$200.83 M | $21.80 M(-63.0%) | -$200.83 M(+43.8%) |
| Sept 2021 | - | $58.97 M(>+9900.0%) | -$139.61 M(-42.7%) |
| June 2021 | - | $458.00 K(-100.2%) | -$243.63 M(-34.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$282.05 M(-439.7%) | -$373.07 M(+604.0%) |
| Dec 2020 | -$52.99 M(-75.6%) | $83.02 M(-284.3%) | -$52.99 M(-65.3%) |
| Sept 2020 | - | -$45.05 M(-65.1%) | -$152.91 M(-49.9%) |
| June 2020 | - | -$128.98 M(-439.2%) | -$305.20 M(+72.6%) |
| Mar 2020 | - | $38.02 M(-325.0%) | -$176.80 M(-18.6%) |
| Dec 2019 | -$217.25 M(+932.8%) | -$16.90 M(-91.4%) | -$217.25 M(+6.5%) |
| Sept 2019 | - | -$197.34 M(>+9900.0%) | -$203.95 M(+2727.2%) |
| June 2019 | - | -$583.00 K(-76.0%) | -$7.21 M(-12.9%) |
| Mar 2019 | - | -$2.43 M(-32.6%) | -$8.29 M(-60.6%) |
| Dec 2018 | -$21.04 M(+4433.6%) | -$3.60 M(+494.9%) | -$21.04 M(+20.6%) |
| Sept 2018 | - | -$605.00 K(-63.4%) | -$17.44 M(+3.6%) |
| June 2018 | - | -$1.66 M(-89.1%) | -$16.83 M(+10.9%) |
| Mar 2018 | - | -$15.18 M | -$15.18 M |
| Dec 2017 | -$464.00 K | - | - |
FAQ
- What is BridgeBio Pharma annual cash flow from investing activities?
- What is the all time high annual CFI for BridgeBio Pharma?
- What is BridgeBio Pharma annual CFI year-on-year change?
- What is BridgeBio Pharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly CFI year-on-year change?
- What is BridgeBio Pharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for BridgeBio Pharma?
- What is BridgeBio Pharma TTM CFI year-on-year change?
What is BridgeBio Pharma annual cash flow from investing activities?
The current annual CFI of BBIO is $54.03 M
What is the all time high annual CFI for BridgeBio Pharma?
BridgeBio Pharma all-time high annual cash flow from investing activities is $453.15 M
What is BridgeBio Pharma annual CFI year-on-year change?
Over the past year, BBIO annual cash flow from investing activities has changed by -$399.11 M (-88.08%)
What is BridgeBio Pharma quarterly cash flow from investing activities?
The current quarterly CFI of BBIO is $38.23 M
What is the all time high quarterly CFI for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly cash flow from investing activities is $149.70 M
What is BridgeBio Pharma quarterly CFI year-on-year change?
Over the past year, BBIO quarterly cash flow from investing activities has changed by +$544.00 K (+1.44%)
What is BridgeBio Pharma TTM cash flow from investing activities?
The current TTM CFI of BBIO is $63.95 M
What is the all time high TTM CFI for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM cash flow from investing activities is $456.98 M
What is BridgeBio Pharma TTM CFI year-on-year change?
Over the past year, BBIO TTM cash flow from investing activities has changed by -$8.11 M (-11.26%)